Progentec Diagnostics, Inc., (?Progentec?) aims to explore and commercialize state of the art diagnostic solutions in therapeutic areas with a high level of unmet need. The company?s current project is an advanced state-of-the-art lupus flare diagnostic, which has potential to fundamentally change the current treatment paradigm for lupus.
TML performs a variety of diagnostic services, including tissue, cytology, bone marrow examinations, clinical consultations, blood bank services, peripheral blood and other body fluid smear consultations, and frozen section evaluation.
ARL offers a full range of professional laboratory services including; potency, sterility, endotoxin, compendial testing, as well as consulting services, research and development and forensic legal support.
Emerson Resources provides pre-formulation through phase III and small commercial production. They have been producing phase I and II clinical supplies since 2005 and will be adding phase III and small volume and orphan drug commercial manufacturing in 2013.
Glomics, Inc. targets global genomics technologies, develops microarray-based technologies and provides their associated services to customers working in a variety of fields involved in microbial functional genomics, community genomics, microbial ecology, environmental microbiology, and geobiochemistry.
Haus Bioceuticals is developing safe and effective products, including Metaderm. Metaderm resolves eczema through a vast combination of spagyric essenses formulated specifically to address the immune signaling disregulation associated with atopic dermatitis and eczema.
Inoveon is a premier medical services company that delivers solutions to detect, stage and monitor diseases affecting the eye – diabetic retinopathy, macular degeneration, and glaucoma. Inoveon’s initial target is to help patients and their providers improve diabetic retinopathy care through Inoveon diagnostic service centers that are co-located in high volume diabetes care sites.
LabCorp?s mission is to improve American healthcare by providing the highest quality cancer and genomic diagnostic services and personalized health information to physicians, patients, and health plans throughout the country.